Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
|
| gptkbp:activeIngredient |
gptkb:paracetamol
gptkb:codeine |
| gptkbp:alternativeTo |
gptkb:Panadeine_Extra
gptkb:Panadeine_Forte |
| gptkbp:availableOn |
gptkb:Australia
|
| gptkbp:contraindication |
allergy to paracetamol
allergy to codeine |
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Panadeine
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:notRecommendedFor |
children under 12
pregnant women (without medical advice) |
| gptkbp:overdoseSymptoms |
liver damage (due to paracetamol)
respiratory depression (due to codeine) |
| gptkbp:regulates |
pharmacy medicine
prescription only (since 2018 in Australia) |
| gptkbp:riskFactor |
addiction (due to codeine)
|
| gptkbp:sideEffect |
nausea
constipation drowsiness |
| gptkbp:usedFor |
pain relief
|
| gptkbp:bfsParent |
gptkb:Codeine
gptkb:codeine |
| gptkbp:bfsLayer |
6
|